135 related articles for article (PubMed ID: 16396086)
1. Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.
Ogungbo B; Prakash S; Ushewokunze S; Etherson K; Sinar J
J Neurosci Nurs; 2005 Dec; 37(6):326-8, 333. PubMed ID: 16396086
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.
Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
J Neurosurg; 2004 Feb; 100(2):359-60; author reply 360. PubMed ID: 15086250
[No Abstract] [Full Text] [Related]
3. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage.
Treggiari MM; Walder B; Suter PM; Romand JA
J Neurosurg; 2003 May; 98(5):978-84. PubMed ID: 12744357
[TBL] [Abstract][Full Text] [Related]
6. The impact of temporary clipping during aneurysm surgery on the incidence of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
J Neurosurg; 2018 Jul; 129(1):84-90. PubMed ID: 28946178
[TBL] [Abstract][Full Text] [Related]
7. Antiischemic therapy of severe prolonged vasospasm after aneurysmal SAH: effects on quality of life.
Kreitschmann-Andermahr I; Hütter BO; Gilsbach JM
Acta Neurochir Suppl; 2001; 77():251-4. PubMed ID: 11563300
[No Abstract] [Full Text] [Related]
8. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.
Krayenbühl N; Hegner T; Yonekawa Y; Keller E
Acta Neurochir Suppl; 2001; 77():247-50. PubMed ID: 11563298
[No Abstract] [Full Text] [Related]
9. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.
Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Igarashi Y; Yokota H;
Neurocrit Care; 2014 Dec; 21(3):462-9. PubMed ID: 24865266
[TBL] [Abstract][Full Text] [Related]
10. "Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH; Lukovits T; Friedman JA
Neurocrit Care; 2006; 4(1):68-76. PubMed ID: 16498198
[TBL] [Abstract][Full Text] [Related]
11. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.
Meyer R; Deem S; Yanez ND; Souter M; Lam A; Treggiari MM
Neurocrit Care; 2011 Feb; 14(1):24-36. PubMed ID: 20838932
[TBL] [Abstract][Full Text] [Related]
12. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.
Egge A; Waterloo K; Sjøholm H; Solberg T; Ingebrigtsen T; Romner B
Neurosurgery; 2001 Sep; 49(3):593-605; discussion 605-6. PubMed ID: 11523669
[TBL] [Abstract][Full Text] [Related]
15. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
16. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.
Origitano TC; Wascher TM; Reichman OH; Anderson DE
Neurosurgery; 1990 Nov; 27(5):729-39; discussion 739-40. PubMed ID: 2259403
[TBL] [Abstract][Full Text] [Related]
17. Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm.
Eddleman CS; Hurley MC; Naidech AM; Batjer HH; Bendok BR
Neurosurg Focus; 2009; 26(3):E6. PubMed ID: 19249962
[TBL] [Abstract][Full Text] [Related]
18. Lower incidence of transcranial Doppler and symptomatic vasospasm after aneurysmal subarachnoid hemorrhage and aneurysm clipping in the elderly patient?
Wachter D; Hans F; Kreitschmann-Andermahr I; Rohde V
Neurosurgery; 2011 Aug; 69(2):261-6; discussion 266-7. PubMed ID: 21499142
[TBL] [Abstract][Full Text] [Related]
19. The present role of "triple-H" therapy in the management of cerebral vasospasm.
Findlay JM
World Neurosurg; 2010; 74(2-3):244-6. PubMed ID: 21492545
[No Abstract] [Full Text] [Related]
20. Cerebral infarction secondary to vasospasm after perimesencephalic subarachnoid hemorrhage.
Fernandez A; Bond RL; Aziz-Sultan MA; Olvey SE; Mangat HS
J Clin Neurosci; 2011 Jul; 18(7):994-6. PubMed ID: 21565507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
